Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I

Neurology

Volumn 68, Issue 3, 2007, Pages 206-213

  Puccioni Sohler, M ^a,b,f   Yamano, Y ^d   Rios, M ^e   Carvalho, S M F ^f   Vasconcelos, C C F ^a,c   Papais Alvarenga, R ^a   Jacobson, S ^d  

^a HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

^b Neurolife Cerebrospinal Fluid Laboratory   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T LYMPHOTROPIC VIRUS TYPE 1 ASSOCIATED MYELOPATHY; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SERODIAGNOSIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS INFECTIVITY; VIRUS LOAD;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; PARAPARESIS, TROPICAL SPASTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 33846228321     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000251300.24540.c4     Document Type: Article

References (26)

1. Osame M. Review of WHO Kagoshima Meeting and diagnostic guidelines for HAM/TSP In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990:191-197.
2. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000;47:831-835.
3. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
4. Puccioni-Sohler M, Rios M, Carvalho SMF, et al. Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index. Neurology 2001;57:725-727.
5. Lezin A, Olindo S, Oliere S, et al. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis? J Infect Dis 2005;191:1830-1834.
6. Kurtzke JF, Beebe GW, Nagler B, Kurland Lt, Auth TL. Studies on the natural history of multiple sclerosis. Early prognostic features of the later course of the illness. J Chronic Dis 1977;30:819-830.
7. Adams RD, Victor M, Ropper A. Principles of neurology. 6th ed. New York: McGraw-Hill, 1997.
8. Rios M, Khabbaz RF, Kaplan JE, Hall WW, Kessler D, Bianco C. Transmission of human T cell lymphotrophic virus (HTLV-I) type II by transfusion of HTLV-I screened blood products. J Infect Dis 1994;160:206-210.
9. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chem 1987;163:319-328.
10. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998;4:586-593.
11. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-2069.
12. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000;21:702-706.
13. Howard AK, Li DK, Oger J. MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives. Can J Neurol Sci 2003;30:41-48.
14. Kuroda Y, Matsui M, Yukitake M, et al. Assessment of MRI criteria for MS in Japanese MS and HAM/TSP. Neurology 1995;45:30-33.
15. Callegaro D, Goldbaum M, Morais L, et al. The prevalence of multiple sclerosis in the city of São Paulo, Brazil, in 1997. Acta Neurol Scand 2001;104:208-213.
16. Vasconcelos CC, Miranda-Santos CM, Alvarenga RM. Clinical course of progressive multiple sclerosis in Brazilian patients. Neuroepidemiology 2006;26:233-239.
17. Papais-Alvarenga RM, Alves-Leon SV, Miranda Santos CM. South Atlantic Project: a Brazilian multiple sclerosis trial. In: Arriaga RC, Nogales-Gaete J, eds. Esclerosis mu ltiple. Una mirada iberopanamericana. Santiago, Chile: Arrynog-Ediciones, 2002:129-154.
18. Galvão-Castro B, Loures L, Rodrigues LG, et al. Distribution of human T-lymphotropic virus type I among blood-donors: a nationwide Brazilian study. Transfusion 1997;37:242-243.
19. Carvalho SMF, Pombo de Oliveira MS, Thuler LCS, et al. HTLV-I and HTLV-II infection in hematologic disorder patients, cancer patients and healthy individuals from Rio de Janeiro, Brazil. J AIDS 1997;15:238-242.
20. Grimaldi LM, Roos RP, Devare SG, et al. HTLV-I associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Ann Neurol 1988;24:727-731.
21. Kitze B, Puccioni-Sohler M, Schaffner J, et al. Specificity of intrathecal IgG synthesis for HTLV-I core and envelope proteins in HAM/TSP. Acta Neurol Scand 1995;92:213-217.
22. Sindic CJ, Monteyne P, Laterre EC. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 1994;54:75-80.
23. Yamano Y, Nagai M, Brennan M, et al. Correlation of human T-cell lymphotropic virus type I (HTLV-I) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002;99:88-94.
24. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol 2001;7:228-234.
25. Puccioni-Sohler M, Chimelli L, Merçon M, et al. Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflammation. J Neurol Sci 2003;207:87-93.
26. Puccioni-Sohler M, Rios M, Bianco C, et al. An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM. Neurology 1999;53:1335-1339.